biotech binary events | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
biotech binary events

An SI Board Since March 2003

Posts	SubjectMarks	Bans
295	36	0

Emcee: dalroi	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
145	As WE indicated recommending and upgrading OSIP target price, even IF NSCLC fail	Miljenko Zuanic	-	3/10/2004
144	An upgrade shortly before a hugely important pivotal trial, arguing you'll b	keokalani'nui	-	3/10/2004
143	>>10:01AM OSIP tgt raised to $43 at BofA Sec 38.02 +0.54: BofA Sec is rais	tuck	-	3/10/2004
142	Not exactly a binary event, but quite a bit of news due from Vernalis in Q2 - &	nigel bates	-	1/27/2004
141	Chances for positive results (survival benefit and RR) are slim, imo. However,	Miljenko Zuanic	-	11/3/2003
140	OSIP has been weak since Tarceva followed in Iressa's footsteps by failing i	tuck	-	11/3/2003
139	<i>GERN has a binary event coming up </i> Not funny for those who h	tom pope	-	10/29/2003
138	Stefaan, December series optioons are now available for SEPR. Cheers, Tuck	tuck	-	10/28/2003
137	CV Therapeutics' Ranexa: Odds For Approval Good' By Randall Osborne Nati	Icebrg	-	10/25/2003
136	FDA panel to look at CVTX' Ranexa Dec 9: Message 19428649 Cheers, Tuck	tuck	-	10/23/2003
135	Also some upcoming PIIa announcements from VRTX, which just got its 2nd generati	tuck	-	10/22/2003
134	Nigel, I know you and Peter have seen this, but felt it was worth cross posting	tuck	-	10/19/2003
133	From the NRGN thread: <I>...We believe Neurogen is the first of the clini	nigel bates	-	10/18/2003
132	FDA will respond with non-approvable letter, at this time. More trials is must,	Miljenko Zuanic	-	10/15/2003
131	The health care hedge fund guys seem pretty certain the drug will not pass. Mik	Michael Young	-	10/15/2003
130	CVTX volatility is rising, which is to be expected: ivolatility.com	tom pope	-	10/15/2003
129	It hasn't been officially deferred yet. It's getting so close to decisio	rkrw	-	10/15/2003
128	>>Will the fda decide or ask for more time? Deadline is closing in.<<	keokalani'nui	-	10/15/2003
127	10/30 PDUFA. What do you guys think? Will the fda decide or ask for more time? D	rkrw	-	10/15/2003
126	>>Isn't that the point ? In a large market, small (dis)/advantages can	Icebrg	-	10/7/2003
125	<i>current studies will just define how well it does</i> Isn't	nigel bates	-	10/7/2003
124	>>NPSP, March(?) '04>> I don't think that will be very bina	Icebrg	-	10/7/2003
123	NPSP, March(?) '04 Message 19379805 NPS announced that it has completed dos	nigel bates	-	10/7/2003
122	The reviewer's opinion may be characterized as relatively benign: <i>	Icebrg	-	9/24/2003
121	FDA Briefing materials:CEPH fda.gov	michael_f_murphy	-	9/24/2003

Go to reply# or date (mm/dd/yy):